PWP2 expression based on
|
Comparison | Statistical significance |
Normal-vs-Primary | 1.550400E-04 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.620000E-03 |
Normal-vs-Stage2 |
9.55110000000481E-05 |
Normal-vs-Stage3 |
2.1447999999924E-05 |
Normal-vs-Stage4 |
1.624270E-03 |
Stage1-vs-Stage2 |
1.146810E-01 |
Stage1-vs-Stage3 |
6.035500E-02 |
Stage1-vs-Stage4 |
2.543400E-01 |
Stage2-vs-Stage3 |
8.542800E-01 |
Stage2-vs-Stage4 |
7.441600E-01 |
Stage3-vs-Stage4 |
8.301200E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
2.202900E-04 |
Normal-vs-AfricanAmerican |
5.389800E-01 |
Normal-vs-Asian |
2.764300E-02 |
Caucasian-vs-AfricanAmerican |
4.552000E-02 |
Caucasian-vs-Asian |
2.910000E-01 |
AfricanAmerican-vs-Asian |
2.403600E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
9.011700E-04 |
Normal-vs-Female |
1.595970E-04 |
Male-vs-Female |
9.532000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
5.182600E-03 |
Normal-vs-Age(41-60Yrs) |
1.040450E-04 |
Normal-vs-Age(61-80Yrs) |
1.034300E-04 |
Normal-vs-Age(81-100Yrs) |
3.585800E-01 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.331560E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.475560E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
6.633200E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.647000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
3.599400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.095200E-01 |
|
|
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Classical-VS-Tall |
2.483800E-02 |
Classical-VS-Follicular |
2.426700E-04 |
Classical-VS-Other |
2.218400E-01 |
Classical-VS-Normal |
4.202600E-03 |
Tall-VS-Follicular |
8.611000E-01 |
Tall-VS-Other |
9.481000E-01 |
Tall-VS-Normal |
7.96060000000098E-05 |
Follicular-VS-Other |
9.749600E-01 |
Follicular-VS-Normal |
5.00600000008511E-07 |
Other-VS-Normal |
1.889990E-02 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.570030E-04 |
Normal-vs-N1 |
1.7068000000009E-06 |
N0-vs-N1 |
4.467700E-02 |
|
|